Suppression_NN
of_IN
human_JJ
anti-porcine_JJ
T-cell_NN
immune_JJ
responses_NNS
by_IN
major_JJ
histocompatibility_NN
complex_NN
class_NN
II_CD
transactivator_NN
constructs_NNS
lacking_VBG
the_DT
amino_NN
terminal_JJ
domain_NN
._.

BACKGROUND_NN
:_:
The_DT
class_NN
II_CD
transactivator_NN
-LRB-_-LRB-
CIITA_NN
-RRB-_-RRB-
is_VBZ
a_DT
bi_NN
-_:
or_CC
multifunctional_JJ
domain_NN
protein_NN
that_WDT
acts_VBZ
as_IN
a_DT
transcriptional_JJ
activator_NN
and_CC
plays_VBZ
a_DT
critical_JJ
role_NN
in_IN
the_DT
expression_NN
of_IN
MHC_NN
class_NN
II_CD
genes_NNS
._.

We_PRP
have_VBP
previously_RB
demonstrated_VBN
that_IN
a_DT
mutated_VBN
form_NN
of_IN
the_DT
human_JJ
CIITA_NN
gene_NN
,_,
coding_VBG
for_IN
a_DT
protein_NN
lacking_VBG
the_DT
amino_NN
terminal_JJ
151_CD
amino_NN
acids_NNS
,_,
acts_VBZ
as_IN
a_DT
potent_JJ
dominant-negative_JJ
suppressor_NN
of_IN
HLA_NN
class_NN
II_CD
expression_NN
._.

Porcine_JJ
MHC_NN
class_NN
II_CD
antigens_NNS
are_VBP
potent_JJ
stimulators_NNS
of_IN
direct_JJ
T-cell_NN
recognition_NN
by_IN
human_JJ
CD4_NN
+_CC
T_NN
cells_NNS
and_CC
are_VBP
,_,
therefore_RB
,_,
likely_JJ
to_TO
play_VB
an_DT
important_JJ
role_NN
in_IN
the_DT
rejection_NN
responses_NNS
to_TO
transgenic_JJ
pig_NN
donors_NNS
in_IN
clinical_JJ
xenotransplantation_NN
._.

We_PRP
were_VBD
,_,
therefore_RB
,_,
interested_VBN
in_IN
examining_VBG
mutated_VBN
CIITA_NN
constructs_NNS
for_IN
their_PRP$
effect_NN
on_IN
porcine_JJ
MHC_NN
class_NN
II_CD
expression_NN
._.

METHODS_NNS
:_:
Stable_JJ
transfectants_NNS
of_IN
the_DT
porcine_JJ
vascular_JJ
endothelial_JJ
cell_NN
line_NN
PIEC_NN
with_IN
mutated_VBN
CIITA_NN
constructs_NNS
were_VBD
tested_VBN
for_IN
SLA-DR_NN
and_CC
SLA-DQ_NN
induction_NN
by_IN
recombinant_JJ
porcine_NN
interferon-gamma_NN
._.

Transient_JJ
transfectants_NNS
of_IN
the_DT
porcine_JJ
B-cell_NN
line_NN
L23_NN
with_IN
the_DT
mutated_VBN
CIITA_NN
constructs_NNS
were_VBD
tested_VBN
for_IN
the_DT
suppression_NN
of_IN
constitutive_JJ
SLA-DR_NN
and_CC
SLA-DQ_NN
expression_NN
._.

T-cell_NN
proliferation_NN
studies_NNS
were_VBD
performed_VBN
using_VBG
highly_RB
purified_VBN
human_JJ
CD4_NN
+_CC
T_NN
cells_NNS
._.

RESULTS_NNS
:_:
In_IN
preliminary_JJ
studies_NNS
,_,
we_PRP
demonstrated_VBD
that_IN
transfection_NN
of_IN
the_DT
PIEC_NN
line_NN
with_IN
full-length_JJ
human_JJ
CIITA_NN
constructs_NNS
resulted_VBD
in_IN
strong_JJ
expression_NN
of_IN
SLA-DR_NN
and_CC
SLA-DQ_NN
antigens_NNS
,_,
thus_RB
establishing_VBG
the_DT
cross-species_JJ
effectiveness_NN
of_IN
human_JJ
CIITA_NN
in_IN
the_DT
pig_NN
._.

The_DT
mutated_VBN
human_JJ
CIITA_NN
constructs_NNS
were_VBD
,_,
therefore_RB
,_,
tested_VBN
in_IN
the_DT
pig_NN
._.

PIEC_NN
clones_NNS
stably_RB
transfected_VBN
with_IN
one_CD
of_IN
these_DT
constructs_NNS
showed_VBD
up_RB
to_TO
99_CD
%_NN
suppression_NN
of_IN
SLA-DR_NN
and_CC
SLA-DQ_NN
antigen_NN
induction_NN
and_CC
marked_JJ
suppression_NN
of_IN
SLA-DRA_NN
mRNA_NN
induction_NN
._.

Moreover_RB
,_,
transient_JJ
transfection_NN
of_IN
the_DT
porcine_JJ
B-cell_NN
line_NN
L23_NN
showed_VBD
up_RB
to_TO
90_CD
%_NN
suppression_NN
of_IN
constitutive_JJ
SLA-DR_NN
and_CC
SLA-DQ_NN
antigen_NN
expression_NN
in_IN
5-8_CD
days_NNS
._.

In_IN
functional_JJ
studies_NNS
,_,
interferon-gamma-stimulated_JJ
PIEC_NN
clones_NNS
transfected_VBN
with_IN
this_DT
mutated_VBN
CIITA_NN
construct_NN
failed_VBD
to_TO
stimulate_VB
purified_VBN
human_JJ
CD4_NN
+_CC
T_NN
lymphocytes_NNS
._.

CONCLUSION_NN
:_:
Mutated_JJ
human_JJ
CIITA_NN
constructs_NNS
are_VBP
potent_JJ
suppressors_NNS
of_IN
porcine_JJ
MHC_NN
class_NN
II_CD
expression_NN
._.

